Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 October 2025
- Conf. stmt due
- 28 January 2027
- Last conf. stmt
- 14 January 2026
Gordian Pharma Limited
- Incorporated
- 20 January 2020 (6 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Michael Grant Wyllie
- Owned by
- Accounts type
- Small
- Region
- South East
- Address
- Wood Centre For Innovation Stansfeld ParkQuarry RoadHeadingtonOxfordOX3 8SB
Officers 4 active
Officer details are public data from the Companies House register.
Director · Appointed 26 November 2025
Also at Mountmorris Developments Ltd · more companies
British
Born April 1943 (83)
Director · Appointed 20 January 2020
British
Born April 1960 (66)
Wyllie, Michael Grant, Dr
Director · Appointed 20 January 2020
British
Born March 1951 (75)
Phillips, Judith Carlyon
Director · Appointed 20 January 2020
British
Born May 1964 (62)
Officer history (3 former)
2 June 2026
26 November 2025
1 July 2024
16 July 2021
16 July 2021
30 June 2020
20 January 2020
20 January 2020
Appointed Wyllie, Michael Grant, Dr as Director
20 January 2020
Appointed Phillips, Judith Carlyon as Director
20 January 2020
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 20 January 2020
Owns 25–50% of shares
Holds 25–50% of voting rights
Private Limited Company
Reg. no. 05115093
Group structure 4 companies
Ownership group derived from the Companies House PSC register
Cardiff Biologicals Limited Owns 75–100% of shares
Cardiff Protides Limited Owns 75–100% of shares
Gordian Pharma Limited This company Owns 25–50% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 9 August 2026 | Accounts for a small company | 31 October 2025 |
Other companies in this industry
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →